JAMDA
Volume 8, Issue 2 , Pages 98-104 , February 2007

Is Drug Therapy for Urinary Incontinence Used Optimally in Long-Term Care Facilities?

  • Siva Narayanan, MS, MHS

      Affiliations

    • Beverly Enterprises, Fort Smith, AR
    • ,
  • Annamaria Cerulli, MPH

      Affiliations

    • Novartis Pharmaceuticals Corporation, East Hanover, NJ
    • Kristijan Kahler and Annamaria Cerulli are employees of Novartis Pharmaceuticals Corporation.
    • ,
  • Kristijan H. Kahler, RPh, MSc, PhD

      Affiliations

    • Novartis Pharmaceuticals Corporation, East Hanover, NJ
    • Kristijan Kahler and Annamaria Cerulli are employees of Novartis Pharmaceuticals Corporation.
    • Corresponding Author InformationAddress correspondence to Kristijan H. Kahler, Novartis Pharmaceuticals Corporation, US CD&MA/Health Economics & Outcomes Research, One Health Plaza, East Hanover, NJ 07936.
    • ,
  • Joseph G. Ouslander, MD

      Affiliations

    • Emory University and the Birmingham/Atlanta VA GRECC, Atlanta, GA.
    • Professor Ouslander serves as a consultant and lecturer for Novartis Pharmaceuticals Corporation and has received educational grant support from this company. He has also served as an advisor and lecturer for Pfizer. At the time of this study Siva Narayanan was an employee of Beverly Enterprises.

References 

  1. Gnanadesigan N, Saliba D, Roth CP, et al. The quality of care provided to vulnerable older community-based patients with urinary incontinence. J Am Med Dir Assoc. 2004;5:141–146
  2. Ouslander JG, Johnson TM. Continence care for frail older adults: It is time to go beyond assessing quality. J Am Med Dir Assoc. 2004;5:213–216
  3. American Medical Directors Association. Urinary Incontinence Clinical Practice Guideline. Columbia, MD: American Medical Directors Association; 1996;
  4. Fantl JA, Newman DK, Colling J, et al. Urinary incontinence in adults: Acute and chronic management. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1996;AHCPR Publication No. 96-0682. Clinical Practice Guideline, No.2, 1996 Update.
  5. Schnelle JF, Smith RL. Quality indicators for the management of urinary incontinence in vulnerable community-dwelling elders. Ann Intern Med. 2001;135:752–758
  6. Centers for Medicare and Medicaid Services. Long-Term Care Resident Assessment Instrument User’s Manual for the Minimum Data Set (MDS), Version 2.0. Baltimore, MD: Centers for Medicare and Medicaid Services; 2002;Available at: www.cms.hhs.gov/quality/mds20/. Accessed January 23, 2006.
  7. Palmer MH, Johnson TM. Quality of incontinence management in US nursing homes: A failing grade. J Am Geriatr Soc. 2003;51:1810–1812
  8. Schnelle JF, Cruise PA, Rahman A, Ouslander JG. Developing rehabilitative behavioral interventions for long-term care: Technology transfer, acceptance, and maintenance issues. J Am Geriatr Soc. 1998;46:771–777
  9. Creason NS, Grybowski JA, Burgener S, et al. Prompted voiding therapy for urinary incontinence in aged female nursing home residents. J Adv Nurs. 1989;14:120–126
  10. Schnelle JF. Treatment of urinary incontinence in nursing home patients by prompted voiding. J Am Geriatr Soc. 1990;38:356–360
  11. Burgio LD, McCormick KA, Scheve AS, et al. The effects of changing prompted voiding schedules in the treatment of incontinence in nursing home residents. J Am Geriatr Soc. 1994;42:315–320
  12. Ouslander JG, Schnelle JF. Incontinence in the nursing home. Ann Intern Med. 1995;122:4348–4349
  13. Ouslander JG, Griffiths P, McConnell E, et al. Functional Incidental Training: Applicability and feasibility in the Veterans Affairs nursing home patient population. J Am Med Dir Assoc. 2005;6:121–127
  14. Resnick NM, Yalla SV, Laurino E. The pathophysiology of urinary incontinence among institutionalized elderly persons. N Engl J Med. 1989;320:1–7
  15. Ouslander JG, Blaustein J, Connor A, Pitt A. Habit training and oxybutynin for incontinence in nursing home patients: A placebo-controlled trial. J Am Geriatr Soc. 1988;36:40–46
  16. Ouslander JG, Schnelle JF, Uman G, et al. Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents? (A placebo-controlled trial). J Am Geriatr Soc. 1995;43:610–617
  17. Ouslander JG, Maloney C, Grasela TH, et al. Implementation of a nursing home urinary incontinence management program with and without tolterodine. J Am Med Dir Assoc. 2001;2:207–214
  18. Center for Health Systems Research and Analysis. Quality indicators for implementation. QI version 6.1 MDS 2.0. University of Wisconsin. Madison, WI: Center for Health System Research and Analysis; 1995;
  19. Ouslander JG, Kane RL, Abrass IB. Urinary incontinence in elderly nursing home patients. JAMA. 1982;248:1194–1198
  20. Brandeis GH, Baumann MM, Hossain M, et al. The prevalence of potentially remediable urinary incontinence in frail older people: A study using the Minimum Data Set. J Am Geriatr Soc. 1997;45:179–184
  21. Wagner TH, Hu TW. Economic costs of urinary incontinence in 1995. Urology. 1998;51:355–361
  22. Gambassi G, Forman DE, Lapane KL, et al. Management of heart failure among very old persons living in long-term care: Has the voice of trials spread? (The SAGE Study Group). Am Heart J. 2000;139:85–93
  23. Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med. 2000;93:457–462
  24. Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med. 1992;117:684–689
  25. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults (Results of a US consensus panel of experts). Arch Intern Med. 2003;163:2716–2724erratum 2004;164:298
  26. Kay GG, Abou-Donia MB, Messer WS, et al. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. J Am Geriatr Soc. 2005;53:2195–2201
  27. Kay G, Crook T, Rekeda L, et al. Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. Eur Urol. 2006;50:317–326
  28. Johnson TM, Ouslander JG, Uman GC, Schnelle JF. Urinary incontinence treatment preferences in long-term care. J Am Geriatr Soc. 2001;49:710–718

 This work was supported by Novartis Pharmaceuticals Corporation. Preparation of the manuscript was supported by Novartis Pharma AG. Editorial and project management services were provided by ACUMED.

PII: S1525-8610(06)00371-9

doi: 10.1016/j.jamda.2006.07.004

JAMDA
Volume 8, Issue 2 , Pages 98-104 , February 2007

Article Tools